Invesco S&P 500 Equal Weight Health Care ETF (RSPH)
| Assets | $756.29M |
| Expense Ratio | 0.40% |
| PE Ratio | 20.81 |
| Shares Out | 23.72M |
| Dividend (ttm) | $0.23 |
| Dividend Yield | 0.70% |
| Ex-Dividend Date | Sep 22, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 14.55% |
| Volume | 62,493 |
| Open | 32.49 |
| Previous Close | 32.55 |
| Day's Range | 32.45 - 32.61 |
| 52-Week Low | 26.36 |
| 52-Week High | 32.62 |
| Beta | 0.85 |
| Holdings | 62 |
| Inception Date | Nov 1, 2006 |
About RSPH
Fund Home PageThe Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of US health care companies taken from the S&P 500 Index. RSPH was launched on Nov 1, 2006 and is issued by Invesco.
Top 10 Holdings
17.37% of assets| Name | Symbol | Weight |
|---|---|---|
| Centene Corporation | CNC | 1.80% |
| Pfizer Inc. | PFE | 1.78% |
| West Pharmaceutical Services, Inc. | WST | 1.77% |
| Becton, Dickinson and Company | BDX | 1.74% |
| Edwards Lifesciences Corporation | EW | 1.73% |
| AbbVie Inc. | ABBV | 1.72% |
| Gilead Sciences, Inc. | GILD | 1.72% |
| Bristol-Myers Squibb Company | BMY | 1.72% |
| Cardinal Health, Inc. | CAH | 1.71% |
| Abbott Laboratories | ABT | 1.70% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2025 | $0.05991 | Sep 26, 2025 |
| Jun 23, 2025 | $0.05546 | Jun 27, 2025 |
| Mar 24, 2025 | $0.05505 | Mar 28, 2025 |
| Dec 23, 2024 | $0.0569 | Dec 27, 2024 |
| Sep 23, 2024 | $0.05474 | Sep 27, 2024 |
| Jun 24, 2024 | $0.05076 | Jun 28, 2024 |
Performance
RSPH had a total return of 5.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.93%.
News
RSPH: The Case Of A Competitive Equal Weight
RSPH is an equal-weight ETF on the healthcare market that replicates the S&P 500 Equal Weight Health Care Index. Its composition makes it more diversified and gives more room for the mid-cap healthcar...
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discoun...
Final Trades: Apple, Palo Alto Networks, Western Union and the RSPH
The Investment Committee give you thieir top stocks to watch for the second half.
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US admini...
RSPH: Outperformance In 2025 Expected
Invesco S&P 500 Equal Weight Health Care ETF's equal-weight strategy should outperform in a lower rate environment, despite its higher expense ratio compared to market-cap weighted ETFs. The healthcar...
RSPH: Healthcare Dashboard For May 2024
This monthly article series shows aggregate industry metrics in the healthcare sector. All healthcare subsectors are overvalued based on my metrics. Pharmaceuticals/biotechnology has the lowest scores...
RSPH: The Time For Healthcare And Equal Weight Will Come
Healthcare may benefit from a reallocation away from large-cap Technology as investors seek better value. Invesco S&P 500® Equal Weight Health Care ETF provides diversified exposure to the healthcare ...
RSPH: Balanced Outlook, Look For Selective Opportunities Over Broad Holdings
Various stages of the market + business cycle call for rotational strategies in tactical allocation. Healthcare emerges as one standout in defensive markets and is worth a thoughtful analysis. Q3 earn...